From immunomodulatory drugs to microRNA therapy
Inflammatory bowel disease (IBD) refers to a group of chronic intestinal inflammatory conditions, primarily ulcerative colitis (UC) and Crohn’s disease (CD). These autoimmune mucosal damage conditions cause pain, bloating, indigestion, and acute abdominal emergencies, significantly reducing quality of life in the long term. Newer treatments have emerged based on a better understanding of the pathophysiology […]